Cerebral Microdialysis-Based Interventions Targeting Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage.
Cerebral microdialysis
Clinical application
Delayed cerebral ischemia
Subarachnoid hemorrhage
Journal
Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
09
12
2021
accepted:
14
03
2022
pubmed:
30
4
2022
medline:
19
7
2022
entrez:
29
4
2022
Statut:
ppublish
Résumé
Delayed cerebral ischemia (DCI), a complication of subarachnoid hemorrhage (SAH), is linked to cerebral vasospasm and associated with poor long-term outcome. We implemented a structured cerebral microdialysis (CMD) based protocol using the lactate/pyruvate ratio (LPR) as an indicator of the cerebral energy metabolic status in the neurocritical care decision making, using an LPR ≥ 30 as a cutoff suggesting an energy metabolic disturbance. We hypothesized that CMD monitoring could contribute to active, protocol-driven therapeutic interventions that may lead to the improved management of patients with SAH. Between 2018 and 2020, 49 invasively monitored patients with SAH, median Glasgow Coma Scale 11 (range 3-15), and World Federation of Neurosurgical Societies scale 4 (range 1-5) on admission receiving CMD were included. We defined a major CMD event as an LPR ≥ 40 for ≥ 2 h and a minor CMD event as an LPR ≥ 30 for ≥ 2 h. We analyzed 7,223 CMD samples over a median of 6 days (5-8). Eight patients had no CMD events. In 41 patients, 113 minor events were recorded, and in 23 patients 42 major events were recorded. Our local protocols were adhered to in 40 major (95%) and 98 minor events (87%), with an active intervention in 32 (76%) and 71 (63%), respectively. Normalization of energy metabolic status (defined as four consecutive samples with LPR < 30 for minor and LPR < 40 for major events) was seen after 69% of major and 59% of minor events. The incidence of DCI-related infarcts was 10% (five patients), with only two observed in a CMD-monitored brain region. Active interventions were initiated in a majority of LPR events based on CMD monitoring. A low DCI incidence was observed, which may be associated with the active interventions. The potential aid of CMD in the clinical decision-making targeting DCI needs confirmation in additional SAH studies.
Sections du résumé
BACKGROUND
Delayed cerebral ischemia (DCI), a complication of subarachnoid hemorrhage (SAH), is linked to cerebral vasospasm and associated with poor long-term outcome. We implemented a structured cerebral microdialysis (CMD) based protocol using the lactate/pyruvate ratio (LPR) as an indicator of the cerebral energy metabolic status in the neurocritical care decision making, using an LPR ≥ 30 as a cutoff suggesting an energy metabolic disturbance. We hypothesized that CMD monitoring could contribute to active, protocol-driven therapeutic interventions that may lead to the improved management of patients with SAH.
METHODS
Between 2018 and 2020, 49 invasively monitored patients with SAH, median Glasgow Coma Scale 11 (range 3-15), and World Federation of Neurosurgical Societies scale 4 (range 1-5) on admission receiving CMD were included. We defined a major CMD event as an LPR ≥ 40 for ≥ 2 h and a minor CMD event as an LPR ≥ 30 for ≥ 2 h.
RESULTS
We analyzed 7,223 CMD samples over a median of 6 days (5-8). Eight patients had no CMD events. In 41 patients, 113 minor events were recorded, and in 23 patients 42 major events were recorded. Our local protocols were adhered to in 40 major (95%) and 98 minor events (87%), with an active intervention in 32 (76%) and 71 (63%), respectively. Normalization of energy metabolic status (defined as four consecutive samples with LPR < 30 for minor and LPR < 40 for major events) was seen after 69% of major and 59% of minor events. The incidence of DCI-related infarcts was 10% (five patients), with only two observed in a CMD-monitored brain region.
CONCLUSIONS
Active interventions were initiated in a majority of LPR events based on CMD monitoring. A low DCI incidence was observed, which may be associated with the active interventions. The potential aid of CMD in the clinical decision-making targeting DCI needs confirmation in additional SAH studies.
Identifiants
pubmed: 35488171
doi: 10.1007/s12028-022-01492-5
pii: 10.1007/s12028-022-01492-5
pmc: PMC9283139
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
255-266Informations de copyright
© 2022. The Author(s).
Références
de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007;78(12):1365–72.
pubmed: 17470467
doi: 10.1136/jnnp.2007.117655
pmcid: 2095631
Feigin VL, Rinkel GJ, Lawes CM, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke. 2005;36(12):2773–80.
pubmed: 16282541
doi: 10.1161/01.STR.0000190838.02954.e8
Johnston SC, Selvin S, Gress DR. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology. 1998;50(5):1413–8.
pubmed: 9595997
doi: 10.1212/WNL.50.5.1413
Nieuwkamp DJ, Setz LE, Algra A, et al. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009;8(7):635–42.
pubmed: 19501022
doi: 10.1016/S1474-4422(09)70126-7
Dorsch N. A clinical review of cerebral vasospasm and delayed ischaemia following aneurysm rupture. Acta Neurochir Suppl. 2011;110(Pt 1):5–6.
pubmed: 21116906
Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41(10):2391–5.
pubmed: 20798370
doi: 10.1161/STROKEAHA.110.589275
Vergouwen M, Ilodigwe D, Macdonald R. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke. 2011;42(4):924–9.
pubmed: 21311062
doi: 10.1161/STROKEAHA.110.597914
Geraghty JR, Testai FD. Delayed cerebral ischemia after subarachnoid hemorrhage: beyond vasospasm and towards a multifactorial pathophysiology. Curr Atheroscler Rep. 2017;19(12):50.
pubmed: 29063300
doi: 10.1007/s11883-017-0690-x
Rass V, Helbok R. How to diagnose delayed cerebral ischaemia and symptomatic vasospasm and prevent cerebral infarction in patients with subarachnoid haemorrhage. Curr Opin Crit Care. 2021;27(2):103–14.
pubmed: 33405414
doi: 10.1097/MCC.0000000000000798
Suzuki H, Kanamaru H, Kawakita F, et al. Cerebrovascular pathophysiology of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Histol Histopathol. 2021;36(2):143–58.
pubmed: 32996580
Crowley RW, Medel R, Dumont AS, et al. Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke. 2011;42(4):919–23.
pubmed: 21350201
doi: 10.1161/STROKEAHA.110.597005
Li K, Barras CD, Chandra RV, et al. A review of the management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2019;126:513–27.
pubmed: 30898740
doi: 10.1016/j.wneu.2019.03.083
Daou BJ, Koduri S, Thompson BG, Chaudhary N, Pandey AS. Clinical and experimental aspects of aneurysmal subarachnoid hemorrhage. CNS Neurosci Ther. 2019;25(10):1096–112.
pubmed: 31583833
doi: 10.1111/cns.13222
pmcid: 6776745
Hasan D, Wijdicks EF, Vermeulen M. Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Ann Neurol. 1990;27(1):106–8.
pubmed: 2301918
doi: 10.1002/ana.410270118
Dorhout Mees SM, van Dijk GW, Algra A, Kempink DR, Rinkel GJ. Glucose levels and outcome after subarachnoid hemorrhage. Neurology. 2003;61(8):1132–3.
pubmed: 14581680
doi: 10.1212/01.WNL.0000090466.68866.02
Claassen J, Vu A, Kreiter KT, et al. Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med. 2004;32(3):832–8.
pubmed: 15090970
doi: 10.1097/01.CCM.0000114830.48833.8A
Egge A, Waterloo K, Sjøholm H, et al. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery. 2001;49(3):593–605 (discussion 605–6).
pubmed: 11523669
Lennihan L, Mayer SA, Fink ME, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2000;31(2):383–91.
pubmed: 10657410
doi: 10.1161/01.STR.31.2.383
Diringer MN, Bleck TP, Claude Hemphill J 3rd, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–40.
pubmed: 21773873
doi: 10.1007/s12028-011-9605-9
Darby JM, Yonas H, Marks EC, et al. Acute cerebral blood flow response to dopamine-induced hypertension after subarachnoid hemorrhage. J Neurosurg. 1994;80(5):857–64.
pubmed: 8169626
doi: 10.3171/jns.1994.80.5.0857
Venkatraman A, Khawaja AM, Gupta S, et al. Intra-arterial vasodilators for vasospasm following aneurysmal subarachnoid hemorrhage: a meta-analysis. J Neurointerv Surg. 2018;10(4):380–7.
pubmed: 28663521
doi: 10.1136/neurintsurg-2017-013128
Rabinstein AA, Friedman JA, Weigand SD, et al. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke. 2004;35(8):1862–6.
pubmed: 15218156
doi: 10.1161/01.STR.0000133132.76983.8e
Sarrafzadeh A, Vajkoczy P, Bijlenga P, Schaller K. Monitoring in neurointensive care—the challenge to detect delayed cerebral ischemia in high-grade aneurysmal SAH. Front Neurol. 2014;5:134.
pubmed: 25101052
doi: 10.3389/fneur.2014.00134
pmcid: 4104636
Meixensberger J, Vath A, Jaeger M, et al. Monitoring of brain tissue oxygenation following severe subarachnoid hemorrhage. Neurol Res. 2003;25(5):445–50.
pubmed: 12866190
doi: 10.1179/016164103101201823
Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43(6):1711–37.
pubmed: 22556195
doi: 10.1161/STR.0b013e3182587839
Hutchinson PJ, Jalloh I, Helmy A, et al. Consensus statement from the 2014 International Microdialysis Forum. Intensive Care Med. 2015;41(9):1517–28.
pubmed: 26194024
doi: 10.1007/s00134-015-3930-y
pmcid: 4550654
Zhou T, Kalanuria A. Cerebral microdialysis in neurocritical care. Curr Neurol Neurosci Rep. 2018;18(12):101.
pubmed: 30353361
doi: 10.1007/s11910-018-0915-6
Delgado JM, DeFeudis FV, Roth RH, Ryugo DK, Mitruka BM. Dialytrode for long term intracerebral perfusion in awake monkeys. Arch Int Pharmacodyn Ther. 1972;198(1):9–21.
pubmed: 4626478
Reinstrup P, Ståhl N, Mellergård P, et al. Intracerebral microdialysis in clinical practice: baseline values for chemical markers during wakefulness, anesthesia, and neurosurgery. Neurosurgery. 2000;47(3):701–9 (discussion 9–10).
pubmed: 10981758
Helbok R, Madineni RC, Schmidt MJ, et al. Intracerebral monitoring of silent infarcts after subarachnoid hemorrhage. Neurocrit Care. 2011;14(2):162–7.
pubmed: 21125348
doi: 10.1007/s12028-010-9472-9
Patet C, Quintard H, Zerlauth JB, et al. Bedside cerebral microdialysis monitoring of delayed cerebral hypoperfusion in comatose patients with poor grade aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2017;88(4):332–8.
pubmed: 27927702
doi: 10.1136/jnnp-2016-313766
Drake CG. Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg. 1988;68:985–6.
Frontera JA, Claassen J, Schmidt JM, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery. 2006;59(1):21–7 (discussion 21–7).
pubmed: 16823296
Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81–4.
pubmed: 4136544
doi: 10.1016/S0140-6736(74)91639-0
Helbok R, Kofler M, Schiefecker AJ, et al. Clinical use of cerebral microdialysis in patients with aneurysmal subarachnoid hemorrhage—state of the art. Front Neurol. 2017;8:565.
pubmed: 29163332
doi: 10.3389/fneur.2017.00565
pmcid: 5676489
Spencer P, Jiang Y, Liu N, et al. Update: microdialysis for monitoring cerebral metabolic dysfunction after subarachnoid hemorrhage. J Clin Med. 2020;10(1):100.
doi: 10.3390/jcm10010100
pmcid: 7794715
Veldeman M, Albanna W, Weiss M, et al. Invasive multimodal neuromonitoring in aneurysmal subarachnoid hemorrhage: a systematic review. Stroke. 2021;52(11):3624–32.
pubmed: 34304602
doi: 10.1161/STROKEAHA.121.034633
Unterberg AW, Sakowitz OW, Sarrafzadeh AS, Benndorf G, Lanksch WR. Role of bedside microdialysis in the diagnosis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2001;94(5):740–9.
pubmed: 11354405
doi: 10.3171/jns.2001.94.5.0740
Sarrafzadeh AS, Sakowitz OW, Kiening KL, et al. Bedside microdialysis: a tool to monitor cerebral metabolism in subarachnoid hemorrhage patients? Crit Care Med. 2002;30(5):1062–70.
pubmed: 12006804
doi: 10.1097/00003246-200205000-00018
Etminan N, Macdonald RL. Management of aneurysmal subarachnoid hemorrhage. Handb Clin Neurol. 2017;140:195–228.
pubmed: 28187800
doi: 10.1016/B978-0-444-63600-3.00012-X
Origitano TC, Wascher TM, Reichman OH, Anderson DE. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution (“triple-H” therapy) after subarachnoid hemorrhage. Neurosurgery. 1990;27(5):729–39 (discussion 39–40).
pubmed: 2259403
doi: 10.1227/00006123-199011000-00010
Dankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care. 2010;14(1):R23.
pubmed: 20175912
doi: 10.1186/cc8886
pmcid: 2875538
Gathier CS, van den Bergh WM, van der Jagt M, et al. Induced hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial. Stroke. 2018;49(1):76–83.
pubmed: 29158449
doi: 10.1161/STROKEAHA.117.017956
Schmidt JM, Ko SB, Helbok R, et al. Cerebral perfusion pressure thresholds for brain tissue hypoxia and metabolic crisis after poor-grade subarachnoid hemorrhage. Stroke. 2011;42(5):1351–6.
pubmed: 21441155
doi: 10.1161/STROKEAHA.110.596874
pmcid: 3089891
Wilkins RH. Cerebral vasospasm. Crit Rev Neurobiol. 1990;6(1):51–77.
pubmed: 2225095
Andelius TCK, Pedersen MV, Bøgh N, et al. Consequence of insertion trauma—effect on early measurements when using intracerebral devices. Sci Rep. 2019;9(1):10652.
pubmed: 31337819
doi: 10.1038/s41598-019-47052-4
pmcid: 6650456
van der Steen WE, Leemans EL, van den Berg R, et al. Radiological scales predicting delayed cerebral ischemia in subarachnoid hemorrhage: systematic review and meta-analysis. Neuroradiology. 2019;61(3):247–56.
pubmed: 30693409
doi: 10.1007/s00234-019-02161-9
Kronvall E, Undrén P, Romner B, et al. Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration. J Neurosurg. 2009;110(1):58–63.
pubmed: 18847340
doi: 10.3171/2008.7.JNS08178
Ayling OG, Ibrahim GM, Alotaibi NM, Gooderham PA, Macdonald RL. Dissociation of early and delayed cerebral infarction after aneurysmal subarachnoid hemorrhage. Stroke. 2016;47(12):2945–51.
pubmed: 27827324
doi: 10.1161/STROKEAHA.116.014794
Juvela S, Siironen J. Early cerebral infarction as a risk factor for poor outcome after aneurysmal subarachnoid haemorrhage. Eur J Neurol. 2012;19(2):332–9.
pubmed: 21951336
doi: 10.1111/j.1468-1331.2011.03523.x
Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39(11):3015–21.
pubmed: 18688013
doi: 10.1161/STROKEAHA.108.519942
Veldeman M, Albanna W, Weiss M, et al. Invasive neuromonitoring with an extended definition of delayed cerebral ischemia is associated with improved outcome after poor-grade subarachnoid hemorrhage. J Neurosurg. 2020;134(5):1527–34.
pubmed: 32413866
doi: 10.3171/2020.3.JNS20375
Herholz K, Heiss WD. Positron emission tomography in clinical neurology. Mol Imaging Biol. 2004;6(4):239–69.
pubmed: 15262239
doi: 10.1016/j.mibio.2004.05.002
Cremers CH, van der Schaaf IC, Wensink E, et al. CT perfusion and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab. 2014;34(2):200–7.
pubmed: 24281744
doi: 10.1038/jcbfm.2013.208